Product Program year 2024 Source: CMS Open Payments

Cala Trio

Device Neurology

PDI 00851749007092

Open in the dashboard

General payments

$740,220

889 payments

Research payments

$222,603

9 payments

Through program year 2024, $740,220 in general payments and $222,603 in research payments were reported against Cala Trio (Neurology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2024 General $93,353 123
2024 Research $104,342 2
2023 General $455,336 434
2023 Research $96,953 6
2022 General $172,955 321
2022 Research $21,308 1
2021 General $18,576 11

Breakdown

Who paid General payments · program years 2021–2024
  1. Cala Health, Inc. $740,220 889 payments
Top recipients General payments · program year 2024
  1. David Shulkin Internal Medicine · Morristown, NJ $60,000 64% · 12 payments
  2. Massachusetts General Hospital Teaching hospital · MA $15,076 16% · 5 payments
  3. Salima Brillman Psychiatry · Sunnyvale, CA $10,900 12% · 3 payments
  4. Pravin Khemani Neurology · Seattle, WA $4,250 5% · 3 payments
  5. Sherif Ibrahim Diagnostic Radiology · Wayne, MI $450 <1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Internal Medicine $60,000 77% · 1 practitioner
  2. Psychiatry Psychiatry & Neurology $10,915 14% · 2 practitioners
  3. Neurology Psychiatry & Neurology $5,716 7% · 46 practitioners
  4. Diagnostic Radiology Radiology $450 <1% · 1 practitioner
  5. Nurse Practitioner, Family Nurse Practitioner $375 <1% · 16 practitioners

The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. New Jersey $60,147 64% · 2 recipients
  2. Massachusetts $15,076 16% · 1 recipient
  3. California $10,920 12% · 2 recipients
  4. Washington $4,775 5% · 24 recipients
  5. Michigan $549 <1% · 7 recipients

The top 5 of 18 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

889 general · 9 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record